UGN-102 – Top line Phase 3 study results – Mark Schoenberg, MD Bladder 3 Mins Read3 Mark Schoenberg, MD- UrologyGenitourinary (GU) CancerBladder Cancer-The Montefiore Medical Center and The Albert Einstein College of Medicine at UroGen Pharma…
